Atrys Health, S.A., together with its subsidiaries, provides diagnostic services and medical treatments in Spain, Portugal, and Latin America. It operates through three segments: Diagnosis, Oncology, and Preventive Medicine. The company offers integrated diagnostics services comprising structural and molecular pathology, genetics, and nuclear medicine diagnosis; telediagnosis activities in the fields of radiology and cardiology; oncology treatment services, such as chemotherapy, immunotherapy, radiotherapy, and brachytherapy; second opinion and genetic counselling; and diagnostic reports and genetic tests. It also provides telemedicine services, such as teleradiology, telecardiology, teleoncology, teledermatology, teleophthalmology, and teleconsultations; prevention plans for companies, which includes training plans on occupational risk prevention; Smart Data, a technological database for healthcare; and research and development services. The company was formerly known as Althia Health, S.L. and changed its name to Atrys Health, S.A. in May 2016. Atrys Health, S.A. was incorporated in 2007 and is headquartered in Madrid, Spain.
Часто задаваемые вопросы
В каком секторе работает Atrys Health SL (ATRY)?
Atrys Health SL относится к сектору Здравоохранение.
Какова текущая цена акций Atrys Health SL (ATRY)?
По последним данным, цена акций Atrys Health SL составляет 2,53 €, предыдущее закрытие — 2,48 €. За последнюю торговую сессию акции Atrys Health SL выросли на 0,06 €, что соответствует росту на 2,22%.
Выплачивает ли Atrys Health SL (ATRY) дивиденды?
Нет, Atrys Health SL не выплачивает дивиденды.
Какой бета-коэффициент (волатильность) у Atrys Health SL (ATRY)?
У компании Atrys Health SL бета 0.567, что указывает на более низкую волатильность по сравнению с рынком в целом.
